In: European Heart Journal, 2014, vol. 35, no. 40, p. 2839-2848
|
In: European Heart Journal, 2015, vol. 36, no. 8, p. 516-526
|
In: European Heart Journal, 2013, vol. 34, no. 34, p. 2715-2715
|
In: European Heart Journal, 2014, vol. 35, no. 14, p. 903-903
|
In: European Heart Journal, 2008, vol. 29, no. 6, p. 718-725
|
In: Cardiovascular Research, 2013, vol. 97, no. 2, p. 219-229
|
In: Cardiovascular Research, 2011, vol. 89, no. 2, p. 464-472
|
In: European Heart Journal, 2011, vol. 32, no. 21, p. 2713-2722
|
In: Circulation, 2006, vol. 114, no. 14, p. 1512-1521
Background— Subacute stent thrombosis is a major clinical concern, and the search for new molecules to cover stents remains important. Dimethyl sulfoxide (DMSO) is used for preservation of hematopoietic progenitor cells and is infused into patients undergoing bone marrow transplantation. Despite its intravenous application, the impact of DMSO on vascular cells has not been assessed....
|
In: European Heart Journal, 2015, vol. 36, no. 48, p. 3392-3403
|